Source: Journal of diabetes and its complications. Unidade: FM
Subjects: NEFROPATIAS, COLESTEROL, DIABETES MELLITUS, ALBUMINAS
ABNT
LIRA, Aecio Lopes de Araujo et al. Serum albumin modified by carbamoylation impairs macrophage cholesterol efflux in diabetic kidney disease. Journal of diabetes and its complications, v. 35, n. 9, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.jdiacomp.2021.107969. Acesso em: 29 ago. 2024.APA
Lira, A. L. de A., Santana, M. de F. M., Pinto, R. de S., Minanni, C. A., Iborra, R. T., Lima, A. M. S. de, et al. (2021). Serum albumin modified by carbamoylation impairs macrophage cholesterol efflux in diabetic kidney disease. Journal of diabetes and its complications, 35( 9). doi:10.1016/j.jdiacomp.2021.107969NLM
Lira AL de A, Santana M de FM, Pinto R de S, Minanni CA, Iborra RT, Lima AMS de, Giannella MLCC, Passarelli M, Queiroz MS. Serum albumin modified by carbamoylation impairs macrophage cholesterol efflux in diabetic kidney disease [Internet]. Journal of diabetes and its complications. 2021 ; 35( 9):[citado 2024 ago. 29 ] Available from: https://doi.org/10.1016/j.jdiacomp.2021.107969Vancouver
Lira AL de A, Santana M de FM, Pinto R de S, Minanni CA, Iborra RT, Lima AMS de, Giannella MLCC, Passarelli M, Queiroz MS. Serum albumin modified by carbamoylation impairs macrophage cholesterol efflux in diabetic kidney disease [Internet]. Journal of diabetes and its complications. 2021 ; 35( 9):[citado 2024 ago. 29 ] Available from: https://doi.org/10.1016/j.jdiacomp.2021.107969